Key facts
- Again’s last known valuation is $113.5M (May 2024).
- It has raised $66.7M; the latest was Later Stage VC ($12.3M) in Oct 2025.
- Notable investors include MassChallenge, GV, InnoFounder, HV Capital, Denmark's Export and Investment Fund — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Again
- ·The full record, as it builds
Funding rounds
No funding rounds for Again are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Again
Developer of an emission control technology designed to convert CO2 into chemicals and proteins using bacteria. The company's technology is based on a bacterium that consumes CO2 at high temperatures by capturing carbon dioxide from industrial facilities in a bioreactor and converting it into products such as feed for chicken and fish, enabling clients to eliminate expensive emission taxes and reduce their environmental footprint.
- Sector
- Business Products and Services (B2B)
- HQ
- Copenhagen, Denmark
- Founded
- 2020
- Employees
- 50
- Website
- again.bio/
- Ownership
- Privately Held (backing)
Again doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Again shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Again in its N-PORT filings yet. We sweep new filings monthly.